In breast cancer, elevated HMMR activates AURKA and reduces ARPC2 localisation in the mitotic cell cortex, which correlates with micronucleation and the activation of cGAS-STING and non-canonical NF-κB signalling (31). Here, CGAS is linked to breast carcinoma.